Flecainide treats a novel KCNJ2 mutation associated with Andersen-Tawil syndrome

by Hanora A. Van Ert, BSN, Elise C. McCune, Kate M. Orland, MS, Kathleen R. Maginot, MD, Nicholas H. Von Bergen, MD, Craig T. January, MD, PhD, Lee L. Eckhardt, MD, FHRS
Published 2017-02-01